Managing Metadata for Life Science Enterprises

Drug development requires information-intensive work. It behooves Pharmaceutical or Biotechnology companies to establish strong content management systems and processes throughout the drug development cycle. From the scientists leading the drug discovery process to the marketing specialists writing a new drug’s labeling, all contributors need to document their activities for a variety of reasons. More importantly, they need the ability to create, manage, share, and collaborate on key information safely. Any delay caused by poor content management could affect overall time to market — especially critical in this fast-changing, regulatory environment with constant pressure to improve quality, safety, and global access.
A content infrastructure manages the creation, consumption and protection of the information that drives individual, team and enterprise productivity. For content infrastructure to deliver accurate, relevant and complete information, it is critical that the metadata describing the content is modeled, aggregated and distributed across the multiple content management systems deployed in the enterprise. Metadata management manages the creation, use and standardization of metadata to deliver high-integrity content Findability.
SchemaLogic is the leading provider of metadata management solutions for unstructured content. Metadata management enables findability by organizing the terms, definitions and relationships that describe content. Our solutions deliver high-integrity findability by ensuring that all content is readily found; is consumed in a relevant context; and is protected according to policy.